Streetbeat News

Stock Prices

CSCI

COSCIENS Biopharma's shares fell after the company announced that its Phase 3 DETECT-Trial of AEZS-130-P02 did not meet the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:38 pm

BNS

Bank of Nova Scotia shares rose following a report of better-than-expected Q3 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:37 pm

BMO

Bank of Montreal shares declined following the release of disappointing Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:36 pm

PG

P&G CFO Andre Schulten sold 13,041 shares of the company's common stock at $170 per share on August 26, as reported in an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:31 pm

LUV

Elliott Investment Management plans to meet with Southwest Airlines to discuss potential board changes due to 'immense' challenges. Elliott, holding over 9.7% of Southwest's voting power, may push for a proxy fight and has proposed new board candidates. Southwest is open to discussions and plans an investor day on Sept. 26.

Portfolio Pulse from Michael Juliano

August 27, 2024 | 1:29 pm

LEXX

Lexaria Bioscience has announced initial results from a GLP-1 human pilot study, indicating a trend towards higher absorption of DehydraTECH-processed Rybelsus compared to the unprocessed version under fed conditions.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:24 pm

SMCI

Super Micro Computer shares declined following a short report by Hindenburg Research.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:22 pm

SRFM

Canaccord Genuity has maintained a Hold rating on Surf Air Mobility (NYSE:SRFM) and adjusted its price target to $2.2 following a reverse stock split of 1:7.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 1:20 pm

TGT

Jim Cramer announced on CNBC's 'Mad Money' that Target Corporation (NYSE:TGT) is rebounding strongly after surpassing market expectations in its recent earnings report. Target's stock has rallied significantly since last November, and its recent earnings report showed a 43% year-over-year growth. The company raised its full-year 2024 adjusted EPS outlook, fueling analyst optimism.

Portfolio Pulse from Benzinga Neuro

August 27, 2024 | 1:19 pm

AYRWF

Ayr Wellness Inc. (OTC:AYRWF), a U.S. multi-state cannabis operator, has seen a 136% stock surge over the past year but recently faced a 15% decline this quarter. Despite profitability challenges and a modest 1.6% revenue increase, Ayr is focusing on strategic growth, expanding into Ohio and Illinois.

Portfolio Pulse from Patricio Liddle

August 27, 2024 | 1:18 pm